Zoetis (ZTS)
(Delayed Data from NYSE)
$171.30 USD
+1.23 (0.72%)
Updated May 28, 2024 04:00 PM ET
After-Market: $171.39 +0.09 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Brokerage Reports
Zoetis Inc. [ZTS]
Reports for Purchase
Showing records 181 - 200 ( 254 total )
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
On January 12, 2016, Zoetis provided an update on the company?s tax outlook for 2016 and 2017 following the European Commission?s decision to reverse certain Belgium tax benefits.
Provider: G.RESEARCH, LLC
Analyst: KEDRA K